NewsBenzingaETF biotech XBI colpisce un ostacolo dei tassi di interesse mentre si avvicinano più di 40 catalizzatori ETF biotech XBI colpisce un ostacolo dei tassi di interesse mentre si avvicinano più di 40 catalizzatori Benzinga 2026.09.25 20:19 (GMT+0) Open on Benzinga Other news Musk: Expects SpaceX to sell no compute to OpenAI Wall Street prepares for Anthropic IPO frenzy, despite broader AI stock slump Iron Mountain Stock: Is Wall Street Bullish or Bearish? HTX DeepThink: Leverage Flush-Out May Not Mark a Bottom; Weak Spot Demand Could Keep BTC Under Pressure What Wall Street analysts are now saying after Nvidia’s beat-and-raise quarter More Than a Swap: PancakeSwap Rebrands as Pancake Ahead of Mobile App Launch
HTX DeepThink: Leverage Flush-Out May Not Mark a Bottom; Weak Spot Demand Could Keep BTC Under Pressure